Search Within

BLADDER CANCER
Results 1 - 73 of 73
Immunotherapy in Bladder Cancer

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 242-251
Authors: Monali Vasekar, David Degraff and Monika Joshi

Emerging Immunotargets in Bladder Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 7
Page: 757-770
Authors: Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran

Genetic Susceptibility to Risk for Bladder Cancer in Individuals Working in High Risk Occupations

Journal: Current Pharmacogenomics
Volume: 3,Issue: 3
Page: 165-175
Authors: Robert A. Branch, Nancy Paulsen, Raj A. Persad, Patrick J.B. Smith, Christopher Collins, Ann Schwartz, Al Cecchetti, Vincent C. Arena, Kendra Jones and Marjorie Romkes

Bladder Cancer and Stem Cells

Journal: Current Signal Transduction Therapy
Volume: 7,Issue: 3
Page: 209-219
Authors: Tomasz Drewa, Sandra Krzyzanowska, Andrzej Marszalek and Anna Bajek

Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4,Issue: 1
Page: 61-68
Authors: M. Frier

Use of Thiazolidinediones and Risk of Bladder Cancer: Disease or Drugs?

Journal: Current Drug Safety
Volume: 8,Issue: 5
Page: 364-370
Authors: Marloes T. Bazelier, Frank de Vries, Peter Vestergaard, Hubert G.M. Leufkens and Marie L. De Bruin

Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 6
Page: 833-839
Authors: L. Marra, M. Cantile, G. Scognamiglio, L. Marra, S. Perdona, E. La Mantia, M. Cerrone, V. Gigantino, C. Cillo, M. Caraglia, S. Pignata, G. Facchini, G. Botti, S. Chieffi, P. Chieffi and R. Franco

Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives

Journal: Current Stem Cell Research & Therapy
Volume: 9,Issue: 2
Page: 89-101
Authors: Goodwin Jinesh G., Daniel Levi Willis and Ashish M. Kamat

Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action

Journal: Clinical Immunology, Endocrine & Metabolic Drugs
Volume: 3,Issue: 1
Page: 31-38
Authors: Mehrsa Jalalizadeh, Armine K. Smith and Hiroshi Miyamoto

Isothiocyanates in the Chemoprevention of Bladder Cancer

Journal: Current Drug Metabolism
Volume: 5,Issue: 2
Page: 193-201
Authors: Li Tang and Yuesheng Zhang

Advances in Gene Therapy for Bladder Cancer

Journal: Current Gene Therapy
Volume: 3,Issue: 1
Page: 1-11
Authors: Akira Irie

Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 2
Page: 125-136
Authors: Pankaj P. Dangle, Boriana Zaharieva, Hongtao Jia and Kamal S. Pohar

The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 18
Page: 1444-1449
Authors: Bernhard Grubmüller, Morgan Roupret, Alberto Briganti and Shahrokh F. Shariat

Bladder Cancer: A Simple Model Becomes Complex

Journal: Current Genomics
Volume: 13,Issue: 5
Page: 395-415
Authors: Giovanni Battista Di Pierro, Caterina Gulia, Cristiano Cristini, Giorgio Fraietta, Lorenzo Marini, Pietro Grande, Vincenzo Gentile and Roberto Piergentili

Current and Emerging Strategies in Bladder Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 6
Page: 589-603
Authors: Simone Carradori, Cristiano Cristini, Daniela Secci, Caterina Gulia, Vincenzo Gentile and Giovanni Battista Di Pierro

Bladder Cancer: Molecular Determinants of Personalized Therapy

Journal: Current Drug Targets
Volume: 16,Issue: 2
Page: 115-124
Authors: Antonio Lopez-Beltran, Matteo Santoni, Francesco Massari, Chiara Ciccarese, Giampaolo Tortora, Liang Cheng, Holger Moch, Marina Scarpelli, Carlos Reymundo and Rodolfo Montironi

ONCOFID™-P a Hyaluronic Acid Paclitaxel Conjugate for the Treatment of Refractory Bladder Cancer and Peritoneal Carcinosis

Journal: Current Bioactive Compounds
Volume: 7,Issue: 1
Page: 27-32
Authors: Monica Campisi and Davide Renier

Bladder Cancer Stem Cells

Journal: Current Stem Cell Research & Therapy
Volume: 5,Issue: 4
Page: 387-395
Authors: Mai N. Tran, Goodwin Jinesh G., David J. McConkey and Ashish M. Kamat

Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 57-68
Authors: Yiyang Sun, Mai-Kim Cheng, Thomas. R.L.Griffiths, J. Kilian Mellon, Bao Kai, Marina Kriajevska and Margaret M. Manson

Recurrence in Bladder Cancer: A Molecular Dead End?

Journal: Current Genomics
Volume: 4,Issue: 5
Page: 417-434
Authors: John M. S. Bartlett, Joanne Edwards and Ken M. Grigor

Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies

Journal: Current Molecular Medicine
Volume: 11,Issue: 8
Page: 623-632
Authors: I. Zachos, V. Tzortzis, P. A. Konstantinopoulos, A. Karatzas, S. Gravas, M. Melekos and A. G. Papavassiliou

Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer

Journal: Current Drug Therapy
Volume: 5,Issue: 3
Page: 202-210
Authors: Marco Orsatti

Intravesical Therapy of Superficial Bladder Cancer

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 3
Page: 345-359
Authors: Michael D. Melekos and George D. Moutzouris

Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 5
Page: 791-800
Authors: Alejandro Speck- Planche, Valeria V. Kleandrova, Feng Luan and M. N. D. S. Cordeiro

Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics

Journal: Current Drug Metabolism
Volume: 18,Issue: 7
Page: 657-665
Authors: F. Campodonico, S. Di Stasi , G. M. Lev, C. Terrone, L. Bongiovanni, F. Mattioli, V. Pagliarulo and C. Introini

Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice

Journal: Current Gene Therapy
Volume: 12,Issue: 2
Page: 67-76
Authors: Fang Wang, Zhiping Wang, Hongwei Tian, Meijiao Qi, Zhenxing Zhai, Shuwen Li, Renju Li, Hongjuan Zhang, Wenyun Wang, Shenjun Fu, Jianzhong Lu, Ronald Rodriguez, Yinglu Guo and Liqun Zhou

Bladder Cancer: Innovative Approaches Beyond the Diagnosis

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 20
Page: 2219-2236
Authors: R. Piergentili, S. Carradori, C. Gulia, C. De Monte, C. Cristini, P. Grande, E. Santini, V. Gentile and G.B. Di Pierro

Radiotherapy in Transitional Cell Carcinoma of Urinary Bladder Cancer –Where Does it Fit Into Treatment Protocol

Journal: Current Cancer Therapy Reviews
Volume: 11,Issue: 2
Page: 94-101
Authors: Rony Benson, Supriya Mallick, K.P. Haresh, P.K. Julka and G.K. Rath

Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 1
Page: 14-22
Authors: H. Miyamoto, Y. Zheng and K. Izumi

Intravesical Drug Delivery into the Bladder to Treat Cancers

Journal: Current Drug Delivery
Volume: 6,Issue: 3
Page: 227-237
Authors: Jia-You Fang and Zih-Rou Huang

Pioglitazone and Cancer: Angel or Demon?

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 27
Page: 4913-4929
Authors: Michael S. Kostapanos, Moses S. Elisaf and Dimitri P. Mikhailidis

Vitamin D Receptor Agonists, Cancer and the Immune System: An Intricate Relationship

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 12
Page: 1297-1301
Authors: Luciano Adorini, Kenn C. Daniel and Giuseppe Penna

Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 23
Page: 2492-2502
Authors: A. Zouhair, M. Ozsahin, M. Schaffer, S. Albrecht, F. Camus, P. Jichlinski, R.-O. Mirimanoff, A. Bischof Delaloye, J.-Y. Meuwly and J.O. Prior

Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma

Journal: Medicinal Chemistry
Volume: 1,Issue: 6
Page: 611-618
Authors: N. E. Fullerton, M. Boyd, S. C. Ross, S. L. Pimlott, J. Babich, D. Kirk, M. R. Zalutsky and R. J. Mairs

Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 9
Page: 1081-1087
Authors: Zhaowei Zhu, Zhoujun Shen and Chen Xu

Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 26-36
Authors: Vanessa R. Conde, Marco G. Alves, Pedro F. Oliveira and Branca M. Silva

Hedgehog Signaling and Urological Cancers

Journal: Current Drug Targets
Volume: 16,Issue: 3
Page: 258-271
Authors: Katsumi Shigemura and Masato Fujisawa

An Overview of Emerging Immunotargets of Genitourinary Tumors

Journal: Current Drug Targets
Volume: 17,Issue: 7
Page: 750-756
Authors: Rodolfo Montironi, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch and Marina Scarpelli

The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design

Journal: Letters in Drug Design & Discovery
Volume: 4,Issue: 5
Page: 311-317
Authors: Michael Frezza, Claudio N. Verani, Di Chen and Q. Ping Dou

Diffusion-Weighted Magnetic Resonance Imaging in Pelvic Cancer

Journal: Current Medical Imaging Reviews
Volume: 8,Issue: 2
Page: 92-99
Authors: N. M. deSouza, S. Kyriazi and E. Sala

Newer Approaches to the Discovery of Glitazones

Journal: Mini-Reviews in Organic Chemistry
Volume: 10,Issue: 1
Page: 66-72
Authors: Praveen Thaggikuppe Krishnamurthy, Moola Joghee Nanjan Chandrasekar and Moola Joghee Nanjan

Downstream Carcinogenesis Signaling Pathways by Green Tea Polyphenols: A Translational Perspective of Chemoprevention and Treatment for Cancers

Journal: Current Drug Metabolism
Volume: 15,Issue: 1
Page: 14-22
Authors: Guohua Hu, Lei Zhang, Yefei Rong, Xiaoling Ni and Yihong Sun

Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 438-444
Authors: Hsiuying Wang

The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 3
Page: 172-179
Authors: Joanna Cytarska, Krzysztof Skowerski, Szymon Jaworski, Konrad Misiura, Beata Filip-Psurska and Joanna Wietrzyk

The Application of Photofrin II® as a Sensitizing Agent for Ionizing Radiation-A New Approach in Tumor Therapy?

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 10
Page: 1209-1215
Authors: M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, G. Jori, E. Duhmke and A. Hofstetter

Polymorphisms of Human N-Acetyltransferases and Cancer Risk

Journal: Current Drug Metabolism
Volume: 9,Issue: 6
Page: 520-531
Authors: Jose A.G Agundez

Genetic Engineering - A New Era for Cancer Immunotherapy?

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 3
Page: 194-198
Authors: Angelica Loskog and Thomas H. Totterman

Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 11
Page: 1283-1294
Authors: Nuno M.F.S.A. Cerqueira, Susana Pereira, Pedro A. Fernandes and Maria J. Ramos

Trans-Platinum Complexes as Anticancer Drugs: Recent Developments and Future Prospects

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 17
Page: 1611-1618
Authors: S. Radulovic, Z. Tesic and S. Manic

Combination of Photodynamic Therapy with Anti-Cancer Agents

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 17
Page: 1655-1673
Authors: M.-F. Zuluaga and N. Lange

Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 2
Page: 129-136
Authors: Fred Saad and Peter Mulders

Inhibition of Human 5-Lipoxygenase and Anti-Neoplastic Effects by 2-Amino-1,4-Benzoquinones

Journal: Medicinal Chemistry
Volume: 2,Issue: 6
Page: 591-595
Authors: Daniel Poeckel, Timo H.J. Niedermeyer, Hang T.L. Pham, Annett Mikolasch, Sabine Mundt, Ulrike Lindequist, Michael Lalk and Oliver Werz

Gallium in Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 15
Page: 1575-1583
Authors: Michael A. Jakupec and Bernhard K. Keppler

Hydrogen Sulfide Generation in Mammals: The Molecular Biology of Cystathionine-β-Synthase (CBS) and Cystathionine-γ-Lyase (CSE)

Journal: Inflammation & Allergy-Drug Targets (Discontinued)
Volume: 10,Issue: 2
Page: 85-91
Authors: Barbara Renga

Pharmacotherapy for the Metabolic Syndrome

Journal: Current Vascular Pharmacology
Volume: 10,Issue: 2
Page: 187-205
Authors: Arthur L.M. Swislocki, David Siegel and Ishwarlal Jialal

Tumor Protein p63/microRNA Network in Epithelial Cancer Cells

Journal: Current Genomics
Volume: 14,Issue: 7
Page: 441-452
Authors: Edward A. Ratovitski

The Neuroendocrine Component in Bladder Tumors

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 9
Page: 1117-1128
Authors: N. Pompas-Veganzones, P. Gonzalez-Peramato and M. Sanchez-Carbayo

Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 732-737
Authors: Sonia Liberati, Maria B. Morelli, Consuelo Amantini, Matteo Santoni, Massimo Nabissi, Claudio Cardinali and Giorgio Santoni

Targeting Dopaminergic System for Treating Nicotine Dependence

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 137-142
Authors: Sawsan Abuhamdah, Ashraf Khalil and Youssef Sari

Estrogen Catechols Detection as Biomarkers in Schistosomiasis Induced Cancer and Infertility

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 2
Page: 135-138
Authors: Monica C. Botelho, Helena Alves and Joachim Richter

Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology

Journal: Current Drug Metabolism
Volume: 7,Issue: 6
Page: 613-628
Authors: H. M. Bolt and R. Thier

Cytochrome P450 Gene Polymorphism and Cancer

Journal: Current Drug Metabolism
Volume: 5,Issue: 3
Page: 211-224
Authors: Jose A.G. Agundez

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 124-134
Authors: Aamer Abbas, Jimena Blandon, Jennifer Rude, Ahmed Elfar and Debabrata Mukherjee

Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 10
Page: 1239-1254
Authors: Jinhui Zhang, Li Li, Cheng Jiang, Chengguo Xing, Sung-Hoon Kim and Junxuan Lu

N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 672-678
Authors: Sara Castiglioni, Silvana Casati, Roberta Ottria, Pierangela Ciuffreda and Jeanette A.M. Maier

Advanced Assessment of the Endogenous Hormone Level as a Potential Biomarker of the Urogenital Tract Cancer

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 16,Issue: 6
Page: 463-472
Authors: Lucyna Konieczna, Mariusz Belka, Tomasz Baczek, Mateusz Ruszkowski, Wiktoria Struck, Michal Markuszewski, Roman Kaliszan and Marcin Markuszewski

CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis

Journal: Current Drug Safety
Volume: 8,Issue: 5
Page: 296-332
Authors: Jakob Starup-Linde, Øystein Karlstad, Stine Aistrup Eriksen, Peter Vestergaard, Heleen K. Bronsveld, Frank de Vries, Morten Andersen, Anssi Auvinen, Jari Haukka, Vidar Hjellvik, Marloes T. Bazelier, Anthonius de Boer, Kari Furu and Marie L. De Bruin

Improvements in Algorithms for Phenotype Inference: The NAT2 Example

Journal: Current Drug Metabolism
Volume: 15,Issue: 2
Page: 233-249
Authors: Silvia Selinski, Meinolf Blaszkewicz, Katja Ickstadt, Jan G. Hengstler and Klaus Golka

Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 5
Page: 458-476
Authors: P.D. Marcato, W.J. Favaro and N. Duran

microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 9
Page: 817-828
Authors: Hao Yu, Yinhui Lu, Zhaofa Li and Qizhao Wang

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 5
Page: 488-494
Authors: Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 429-429
Authors: Yusuf Tutar

Results 1 - 73 of 73